Suppr超能文献

在高容量中心,腹腔镜胰腺癌切除术与辅助化疗的使用增加及延迟减少相关。

Laparoscopic pancreatectomy for cancer in high volume centers is associated with an increased use and fewer delays of adjuvant chemotherapy.

作者信息

Kutlu Onur C, Vega Eduardo A, Salehi Omid, Lathan Christopher, Kim Sunhee, Krishnan Sandeep, Stallwood Christopher, Kozyreva Olga, Conrad Claudius

机构信息

Department of Surgery, University of Miami, Miller School of Medicine, Miami, FL, USA.

Department of Surgery, Saint Elizabeth Medical Center, Tufts University School of Medicine, Boston, MA, USA.

出版信息

HPB (Oxford). 2021 Apr;23(4):625-632. doi: 10.1016/j.hpb.2020.09.003. Epub 2020 Sep 25.

Abstract

BACKGROUND

This study aimed to investigate the relationship between hospital case volume, surgical approach and AC-use in patients who underwent pancreatectomy for pancreatic ductal adenocarcinoma (PDAC).

METHODS

Patients were divided into quartiles by institutional pancreatectomy case volume, resection type (pancreaticoduodenectomy [PD], distal pancreatectomy [DP], or total pancreatectomy [TP]) and surgical approach (laparoscopic vs. open). The rates and contributing factors of AC administration and delay >90 days were compared among volume quartiles and surgical approaches.

RESULTS

This study identified 23,494 patients who had undergone pancreatectomy for PDAC between 2010 and 2016 and met inclusion criteria. After correcting for confounders, compared to low volume hospitals patients at high-case-volume hospitals had the highest rates of AC administration after PD and DP. Moreover, compared to open surgery for all resection types, laparoscopic surgery was associated with a higher rate of AC use at high and highest-case-volume hospitals and less delay to chemotherapy at high-volume hospitals. For DP, laparoscopic approach had a positive impact on AC delay >90-day at the highest volume institutions only.

CONCLUSIONS

Laparoscopic surgery for pancreatic cancer leads to higher utilization and lower probability of delay of AC in high and highest volume hospitals.

摘要

背景

本研究旨在调查接受胰腺导管腺癌(PDAC)胰腺切除术患者的医院病例数量、手术方式与辅助化疗(AC)使用之间的关系。

方法

根据机构胰腺切除术病例数量、切除类型(胰十二指肠切除术[PD]、胰腺远端切除术[DP]或全胰切除术[TP])和手术方式(腹腔镜手术与开放手术)将患者分为四分位数。比较各四分位数和手术方式之间AC给药率、延迟>90天的发生率及相关因素。

结果

本研究纳入了2010年至2016年间接受PDAC胰腺切除术且符合纳入标准的23494例患者。校正混杂因素后,与低病例数量医院的患者相比,高病例数量医院的患者在PD和DP术后接受AC治疗的比例最高。此外,与所有切除类型的开放手术相比,腹腔镜手术在高病例数量和最高病例数量医院中AC使用率更高,在高病例数量医院中化疗延迟更少。对于DP,仅在最高病例数量机构中,腹腔镜手术方式对AC延迟>90天有积极影响。

结论

在高病例数量和最高病例数量医院中,胰腺癌腹腔镜手术可提高AC利用率并降低延迟可能性。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验